Nasopharyngeal carcinoma – treatment possibilities in patients with primary metastatic carcinoma
Journal Title: OncoReview - Year 2017, Vol 7, Issue 1
Abstract
This article presents methods of effective treatment of primary metastatic nasopharyngeal carcinoma, both causative and symptomatic, taking into account possible available treatment therapies (chemotherapy, targeted therapy, radiotherapy), and includes a case report. The applied treatment allowed for satisfactory control of the disease and much higher overall survival than expected – the patient survived for 53 months from the initial diagnosis and 41 months from being diagnosed with metastatic carcinoma.
Authors and Affiliations
Marek Kowalczyk, Michał Piątek, Dorota Imielska-Zdunek, Aleksandra Derra, Agnieszka Boratyn-Nowicka
Keywords
Related Articles
- EP ID EP187858
- DOI -
- Views 211
- Downloads 0
The evaluation of the efficacy and toxicity of targeted treatment in non-small cell lung cancer patients – single centre experience
Introduction: Tyrosine kinase inhibitors (TKI) are the standard of treatment in patients with advanced non-small cell lung cancer (NSCLC) with EGFR (endothelial growth factor receptor) gene activating mutation. Objecti...
Krwioplucie – rak czy zatorowość płucna?
Pacjenci onkologiczni to grupa o zwiększonym ryzyku wystąpienia zatorowości płucnej. Zarówno w obrazie klinicznym zatorowości płucnej, jak i w przebiegu choroby rozrostowej może wystąpić krwioplucie. Jest ono zawsze obja...
Everolimus in every day practice of metastatic renal cell carcinoma therapy – one center experience
Introduction: Everolimus is a selective mTOR inhibitor which received approval for treatment of advanced renal cell carcinoma (mRCC) after progression on or after treatment with VEGF-targeted therapy. The aim of this stu...
Pheochromocytoma and paraganglioma – an overview
Pheochromocytoma and paraganglioma derive from chromaffin tissue that secretes catecholamines, which determine the characteristic clinical picture of the disease. Serious and potentially fatal cardiovascular complication...
Meeting the human
We often have to deal with problems which force us to making difficult choices and decisions that have not only clinical aspects but also ethical during the oncologist’s work. Unfortunately there is not enough place in a...